Elena Cantone | Medicine and Dentistry | Research Excellence Award

Prof. Dr. Elena Cantone | Medicine and Dentistry | Research Excellence Award

University of Calabria | Italy

Prof. Dr. Elena Cantone is a highly accomplished researcher in the field of otorhinolaryngology, with a strong and sustained impact on clinical and translational research. Her scholarly output comprises 126 peer-reviewed documents, which together have received 1,953 citations from 1,649 citing documents, reflecting wide international recognition of her work. She maintains an h-index of 25, underscoring both the productivity and consistent influence of her research contributions. Her publications address key topics in chronic rhinosinusitis with nasal polyps (CRSwNP), severe asthma comorbidities, cystic fibrosis–related ENT manifestations, nasal cytology, biologic therapies, and multidisciplinary management strategies. She has played a significant role in advancing real-world evidence on biologic treatments such as dupilumab and mepolizumab, contributing to clinical guidelines, composite severity scoring systems, and long-term outcome assessments. Her research is frequently published in high-impact international journals including Allergy, Clinical Otolaryngology, Journal of Clinical Medicine, Journal of Cystic Fibrosis, The Laryngoscope, and Current Allergy and Asthma Reports. Through collaborative, multicenter studies and clinically driven investigations, her work continues to shape evidence-based practice and improve understanding of inflammatory and airway diseases at both national and international levels.

 

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1,953

h-index
25

Documents
126

Citations

h-index

Documents


View Scopus Profile

Featured Publications

Marcel Brown | Medicine and Dentistry | Research Excellence Award

Dr. Marcel Brown | Medicine and Dentistry | Research Excellence Award

Atrium Health Wake Forest Baptist | United States

Dr. Marcel Brown is a clinician–scientist whose research portfolio integrates orthopaedic surgery, regenerative medicine, translational molecular science, and cardiovascular physiology, with a strong emphasis on clinically impactful, mechanism-driven investigation. His scholarly output comprises 7 peer-reviewed documents, which have collectively received 145 citations, reflecting an h-index of 3, indicative of consistent citation impact across his publications. His research experience spans advanced orthopaedic outcomes research, musculoskeletal infection prevention, stem cell and acellular biologic therapies for osteoarthritis and post-traumatic osteoarthritis, and translational studies evaluating tissue regeneration, inflammation, and functional recovery using in vitro, in vivo, and ex vivo models. Complementing this work, he has contributed substantially to cardiovascular and exercise physiology research, including investigations into exercise-induced cardiac remodeling, pulmonary vascular disease, metabolic and hormonal responses to physical stress, and molecular mechanisms underlying maladaptive vascular fibrosis. His interdisciplinary collaborations have resulted in publications across high-impact journals in orthopaedics, translational medicine, cardiovascular science, and cell biology, including original research articles, systematic analyses, and clinically relevant case reports. Collectively, his research demonstrates a sustained commitment to bridging basic science with clinical application, advancing evidence-based surgical practice, regenerative strategies, and cardiometabolic health through rigorously designed translational and outcomes-focused studies.

 

Citation Metrics (Scopus)

150120

90

60

30

0

Citations
145

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Risk factors for failure after lumbar tubular microdecompression without stabilization
– Journal of the American Academy of Orthopaedic Surgeons, 2025

Anna Schiefer | Medicine and Dentistry | Research Excellence Award

Ms. Anna Schiefer | Medicine and Dentistry | Research Excellence Award

Charité – Universitätsmedizin Berlin | Germany

Ms. Anna Schiefer is an emerging researcher whose work focuses on fracture-related infections, prosthetic joint infections, and regenerative approaches in orthopaedics and traumatology. Her research has been presented at several major international conferences, including the Fracture-Related Infections Workshop and Prosthetic Joint Infections Workshop hosted by the PRO-IMPLANT Foundation, as well as the 6th Congress of the European Society of Tissue Regeneration in Orthopaedics and Traumatology and multiple annual meetings of the European Bone and Joint Infection Society. She has contributed posters and oral presentations highlighting key findings from her doctoral research on infection characteristics and outcomes following intramedullary nailing in femur and tibia fractures. Her scholarly engagement began early, with participation in academic meetings such as the Material Driven Regeneration Annual Meeting, Orthopedic Science Day at Maastricht University, the Omkadering van Jonge Onderzoekers Initiative at KU Leuven, and the MOSA biomedical research conference. She has received competitive scholarships from the PRO-IMPLANT Foundation to support cohort studies on fracture-related and prosthetic joint infections, reflecting the clinical relevance of her work. Her contributions have earned notable recognition, including the Silver Prize for Free Papers at the 6th ESTROT Congress. Her 2026 journal article in Injury further underscores her contributions to infection research within trauma surgery.

Profile : Orcid

Featured Publication

**Schiefer, A., Renz, N., Steiner, G., Märdian, S., Stöckle, U., Trampuz, A., & Meller, S. (2026). Infection after intramedullary nailing for femur and tibia fractures: Characteristics and outcome analysis. Injury.

Guido Moro | Medicine and Dentistry | Most Commended Article Award

Prof. Guido Moro | Medicine and Dentistry | Most Commended Article Award

Associazione Italiana Banche del Latte Umano Donato (AIBLUD) | Italy

Prof. Guido Moro is a highly influential researcher whose work has made substantial contributions to neonatal nutrition, human milk science, and milk bank practices worldwide. With 7,641 citations, 156 scholarly documents, and an h-index of 42, his research has shaped international standards for donor human milk banking, maternal nutrition, and infant health. His extensive publication record includes impactful studies on the antiviral properties of human milk glycosaminoglycans, the influence of maternal Mediterranean diet adherence on milk fatty acid composition, and global assessments of milk bank operations during the COVID-19 pandemic. He has been a key contributor to international guidelines on the establishment, safety, and operation of donor milk banks, as well as to authoritative chapters on human milk quality and safety. Recent works address topics such as viral transmission versus protection through milk, dietary patterns among donor mothers, and the evaluation of novel milk fortification strategies. His leadership extends to major collaborative initiatives, including European and global surveys, expert consensus recommendations, and advancements in pasteurization alternatives for human milk processing. With active participation in 326 conferences and 353 presentations, his scientific influence is recognized across clinical, nutritional, and public health communities, making him a leading authority in human milk research and neonatal nutrition.

Profile : Scopus

Featured Publications

De Nisi, G., Moro, G. E., Arslanoglu, S., Ambruzzi, A. M., Bertino, E., Biasini, A., Profeti, C., Salvatori, G., Tonetto, P., Quitadamo, P. A., et al. (2025). The fourth survey on the activity of human milk banks in Italy. Nutrients, 17, 2663.

Gandino, S., Fantauzzi, A., Danese, N., Quitadamo, P., Merusi, I., & Moro, G. E. (2025). Milk donation following perinatal loss: Insights from a survey across Italian human milk banks. Journal of Biomedical Research & Environmental Sciences, 6(4), 388–393.

Moro, G. E., Girard, M., Peila, C., Garcia, N., Escuder-Vieco, N., Keller, K., Cassidy, T., Bertino, E., Boquien, C.-Y., Buffin, R., Calvo, J., Gaya, A., Gebauer, C., Lamireau, D., Lembo, D., Picaud, J.-C., Wesolowska, A., Arslanoglu, S., Cavallarin, L., & Giribaldi, M. (2024). New alternatives to holder pasteurization in donor milk processing in human milk banks. Frontiers in Nutrition, 11, 1409381.

Coutsoudis, A., Ascherl, R., Bertino, E., Garcia-Lara, N., Moro, G. E., Nangia, S., Picaud, J.-C., Shenker, N., Staff, M., Wesolowska, A., & Weaver, G. (2024). Response to concerns on commercial human milk industry from the Global Alliance of Milk Banks and Associations. Pediatric Research.

Peila, C., Spada, E., Deantoni, S., Borsani, M., Asteggiano, M., Chiale, F., Moro, G. E., Giribaldi, M., Cavallarin, L., Cortinovis, I., & Coscia, A. (2024). The use of a novel donkey milk-derived human milk fortifier in the neonatal period and allergic manifestations: The “Fortilat Trial” follow-up. Breastfeeding Medicine, 19(3), 223–227.

Gandino, S., Bzikowska-Jura, A., Karcz, K., Cassidy, T., Wesolowska, A., Kròlak-Olejnik, B., Klotz, D., Arslanoglu, S., Picaud, J.-C., Boquien, C.-Y., Bertino, E., Moro, G. E., & Weaver, G. (2023). Vegan/vegetarian diet and human milk donation: An EMBA survey across European milk banks. Maternal & Child Nutrition, e13564.

Francese, R., Peila, C., Donalisio, M., Lamberti, C., Cirrincione, S., Colombi, N., Tonetto, P., Bertino, E., Moro, G. E., Coscia, A., & Lembo, D. (2023). Viruses and human milk: Transmission or protection? Advances in Nutrition, 14(6), 1389–1415.

Moro, G. E., & Profeti, C. (2023). Recommendations for addressing food safety concerns in human milk banks. Food Safety Magazine.

Arslanoglu, S., Moro, G. E., Tonetto, P., De Nisi, G., Ambruzzi, A. M., Biasini, A., Profeti, C., Gagliardi, L., Salvatori, G., & Bertino, E. (2023). Recommendations for the establishment and operation of a donor human milk bank. Nutrition Reviews, 81(S1), 1–28.

Bertino, E., Gaya, P. A., & Moro, G. E. (2022). Human milk. In Guide to the Quality and Safety of Tissues and Cells for Human Application (5th ed., pp. 373–383). EDQM.

De Nisi, G., Moro, G. E., Arslanoglu, S., Ambruzzi, A. M., Biasini, A., Profeti, C., Tonetto, P., Bertino, E., & AIBLUD Members. (2022). The third survey on the activity of human milk banks in Italy and the impact of the COVID-19 pandemic. International Journal of Nutrition, 7(2), 31–41.

Di Maso, M., Bravi, F., Ferraroni, M., Agostoni, C., Eussen, S. R. B. M., Decsi, T., Quitadamo, P. A., Tonetto, P., Peila, C., Profeti, C., Salvatori, G., Kazmierska, I., Decarli, A., Vacca, E., Bertino, E., Stahl, B., & Moro, G. E. (2022). Adherence to Mediterranean diet of breastfeeding mothers and fatty acids composition of their human milk: Results from the Italian MEDIDIET study. Frontiers in Nutrition, 9, Article 891376.

Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Andrea Sonaglioni | Medicine and Dentistry | Best Researcher Award

Dr. Andrea Sonaglioni | Medicine and Dentistry | Best Researcher Award

MultiMedica IRCCS | Italy

Dr. Andrea Sonaglioni is a distinguished cardiologist and medical researcher recognized for his extensive contributions to cardiovascular imaging and clinical cardiology. Serving as Medical Director of the Echocardiography Unit at the San Giuseppe Hospital, MultiMedica S.p.A. in Milan, he has developed deep expertise in non-invasive cardiovascular diagnostics, including transthoracic, transesophageal, and stress echocardiography. His research interests span cardio-oncology, cardio-obstetrics, pulmonary hypertension, and cardiac mechanics, with an emphasis on translational and imaging-based studies. Dr. Sonaglioni has authored 112 scientific publications in high-impact international journals, with his works cited 988 times by 674 documents, reflecting his strong influence in the field. He maintains an h-index of 20, underscoring the lasting significance of his research. In addition to his investigative and clinical achievements, he serves as a reviewer for leading cardiovascular journals and has presented numerous papers at national and international conferences. His ongoing projects, including the CARTOX-PREDICT study on cardiotoxicity in cancer therapy, exemplify his commitment to advancing patient-centered cardiovascular care and integrating innovative diagnostic methodologies into clinical practice.

Profiles : Scopus | Orcid

Featured Publications

Sonaglioni, A., & Nicolosi, G. L. (2025). A paradox within the paradox: Beyond body composition indices, waist circumference, and non-radiological anteroposterior thoracic diameter as predictors of subclinical myocardial dysfunction in obesity. Echocardiography.

Sonaglioni, A., Nicolosi, G. L., Bruno, A., & Lombardo, M. (2025). Accuracy of noninvasive screening exercise tests for detecting coronary artery disease in symptomatic patients with mitral valve prolapse: A systematic review. Journal of Cardiovascular Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Muti, P. (2025). Could pulsed wave tissue Doppler imaging solve the diagnostic dilemma of right atrial masses and pseudomasses? A case series and literature review. Journal of Clinical Medicine.

Sonaglioni, A., Bruno, A., Nicolosi, G. L., Fossile, E., Rubuano, C., Ricotta, R., Gemelli, M., Lombardo, M., Muti, P., & Bassani, B. (2025). Effect of immune checkpoint inhibitor therapy on biventricular mechanics in cancer patients over a short-term follow-up: A systematic review. Frontiers in Immunology.

Sonaglioni, A., & Nicolosi, G. L. (2025). Is there only cardiac mechanics pathophysiology behind echocardiographic global longitudinal strain and twisting algorithms? International Journal of Cardiology.

Sonaglioni, A., Nicolosi, G. L., & Lombardo, M. (2025). Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis. International Journal of Cardiology.

Sonaglioni, A., & Nicolosi, G. L. (2025). Three-dimensional left atrial strain in hypertensive disorders of pregnancy: A new prognostic frontier? Echocardiography.

Sonaglioni, A., Polymeropoulos, A., Baravelli, M., Nicolosi, G. L., Lombardo, M., & Biondi-Zoccai, G. (2025). Diagnostic accuracy of exercise stress testing, stress echocardiography, myocardial scintigraphy, and cardiac magnetic resonance for obstructive coronary artery disease: Systematic reviews and meta-analyses of 104 studies published from 1990 to 2025. Journal of Clinical Medicine.

Sonaglioni, A., Napoli, F., Dell’Anna, R., Nicolosi, G. L., Bianchi, S., Lombardo, M., Harari, S., & Lonati, C. (2025). Comprehensive assessment of biventricular and biatrial myocardial strain parameters at six years postpartum in a cohort of women with previous hypertensive disorders of pregnancy. Journal of Clinical Medicine.

Sonaglioni, A., Baravelli, M., Caminati, A., Tagariello, F., De Cesco, F., Nicolosi, G. L., Lombardo, M., & Harari, S. (2025). Effect of chronic obstructive pulmonary disease (COPD) on biventricular mechanics in patients without severe airflow obstruction. Journal of Clinical Medicine.

Sonaglioni, A., Cerini, F., Fagiani, V., Nicolosi, G. L., Rumi, M. G., Lombardo, M., & Muti, P. (2025). Effect of metabolic dysfunction-associated steatotic liver disease (MASLD) on left ventricular mechanics in patients without overt cardiac disease: A systematic review and meta-analysis. Journal of Clinical Medicine.

Sonaglioni, A., Lucidi, A., Luisi, F., Caminati, A., Nicolosi, G. L., Rispoli, G. A., Zompatori, M., Lombardo, M., & Harari, S. (2025). A dynamic multimodality imaging assessment of right ventricular thrombosis in a middle-aged man with lymphocytic interstitial pneumonia: The additive role of tissue Doppler imaging. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Rispoli, G. A., Lombardo, M., & Muti, P. (2025). Does preliminary chest shape assessment improve the prognostic risk stratification of individuals with mitral annular disjunction? A case report and narrative review. Journal of Clinical Medicine.

Sonaglioni, A., Casieri, F., Nicolosi, G. L., Bianchi, S., & Lombardo, M. (2025). Comprehensive assessment of biventricular and biatrial myocardial strain parameters at four years postpartum in a cohort of women with previous gestational diabetes mellitus. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Polymeropoulos, A., Lombardo, M., & Muti, P. (2025). Echocardiographic assessment of cardiac structure and function of centenarians: A systematic review. Geriatrics.

Sonaglioni, A., Caminati, A., Behring, G., Nicolosi, G. L., Rispoli, G. A., Zompatori, M., Lombardo, M., & Harari, S. (2025). Prognostic role and determinants of ascending aorta dilatation in non-advanced idiopathic pulmonary fibrosis: A preliminary observation from a tertiary university center. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Muti, P. (2025). The prevalence, pathophysiological role and determinants of mitral annular disjunction among patients with mitral valve prolapse: A systematic review. Journal of Clinical Medicine.

Sonaglioni, A., Caminati, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Harari, S. (2025). Echocardiographic assessment of biventricular mechanics in patients with mild-to-moderate idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Journal of Clinical Medicine.

 

Harvey White | Medicine and Dentistry | Best Researcher Award

Prof. Harvey White | Medicine and Dentistry | Best Researcher Award

Health New Zealand - The Health Network | New Zealand

Author Profile

Scopus

Orcid 

Early Academic Pursuits

Prof. Harvey White’s journey into medicine began with a strong academic foundation that laid the groundwork for his pioneering career in cardiology. His advanced studies culminated in a Doctorate of Science from the University of Otago, where his thesis explored the prognostic importance of cardiac volume and vessel patency in the context of thrombolytic therapy. This formative academic phase instilled in him both a scientific curiosity and a commitment to evidence-based medicine, shaping the direction of his future clinical and research endeavors.

Professional Endeavors

Over the decades, Prof. White has held leading positions in cardiology, serving as a cardiologist and Director of the Cardiovascular Research Unit at Auckland City Hospital, while also contributing as an Honorary Clinical Professor at the University of Auckland. His clinical practice has been marked by a dedication to advancing the treatment of acute coronary syndromes, dyslipidemia, and cardiovascular diseases in the elderly. Beyond hospital walls, his advocacy for patient-centered care and public health initiatives has reinforced his reputation as both a clinician and a community leader.

Contributions and Research Focus

Prof. White has made remarkable contributions in areas such as antithrombotic therapy, the universal definition of myocardial infarction, and biomarker development for acute coronary syndromes. His investigations into lipid-lowering therapies, genetic markers, and cardiovascular outcomes have influenced guidelines and shaped clinical practice worldwide. He has consistently emphasized the integration of clinical trials, translational research, and collaborative studies, ensuring that his findings benefit both scientific communities and patients directly.

Accolades and Recognition

A highly cited researcher, Prof. White’s prolific publication record—spanning books, book chapters, peer-reviewed articles, and clinical guidelines—has earned him recognition among the world’s most influential scientific minds. He has been honored with prestigious awards, including the Prince Mahidol Award for Medicine, fellowship titles from leading cardiology societies, and multiple recognitions for his research excellence and thought leadership. His standing among the top global experts in cardiology reflects not only his scholarly output but also his enduring influence on international medicine.

Impact and Influence

The global impact of Prof. White’s work is evident in both academia and clinical practice. His leadership in redefining myocardial infarction classifications has guided generations of cardiologists, while his advocacy for evidence-based practices has transformed patient care protocols. His influence extends to policy, having advised the World Health Organization on cardiovascular disease prevention and diabetes management in developing nations. As a mentor and educator, he has inspired countless medical professionals to pursue excellence in research and practice.

Legacy and Future Contributions

Prof. White’s legacy is firmly established in the annals of cardiovascular medicine, yet his ongoing contributions suggest that his influence is far from complete. His continuous research into emerging therapies, his role in international collaborations, and his commitment to bridging scientific advancements with real-world healthcare challenges ensure that his impact will continue to grow. By championing innovation while prioritizing patient welfare, he sets a standard for the future of cardiology.

Publications


Article: Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Authors: Harvey D. White, Sean M. O’Brien, William E. Boden, Stephen E. Fremes, Sripal Bangalore, Harmony R. Reynolds, Gregg W. Stone, Ziad A. Ali, Neeraj Parakh, Jose Luis Lopez-Sendon, et al.
Journal: American Heart Journal
Year: 2025


Article: Great Debate: the universal definition of myocardial infarction is flawed and should be put to rest
Authors: Juan-Carlos Kaski, Christian Mueller, Harvey White, Pedro Lopez-Ayala, Ranil de Silva
Journal: European Heart Journal (Other publication type)
Year: 2025


Article: Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Authors: C. Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White, Serge Korjian, John H. Alexander, A. Michael Lincoff, Mark Heise, Bronwyn A. Kingwell, et al.
Journal: European Heart Journal
Year: 2024


Article: Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Authors: Andrew P. DeFilippis, J. Dawn Abbott, Brandon M. Herbert, Marnie H. Bertolet, Bernard R. Chaitman, Harvey D. White, Andrew M. Goldsweig, Tamar S. Polonsky, Rajesh Gupta, Caroline Alsweiler, et al.
Journal: Circulation
Year: 2024


Article: Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis
Authors: Rajan Rehan, Sohaib Virk, Christopher C. Y. Wong, Freda Passam, Jamie Layland, Anthony Keech, Andy Yong, Harvey D. White, William Fearon, Martin Ng
Journal: Heart
Year: 2024


Conclusion

Prof. White’s biography is a testament to the profound difference that one individual can make in shaping modern medicine. His achievements reflect not only a personal dedication to research and patient care but also a broader vision for global cardiovascular health. His legacy, defined by innovation, leadership, and compassion, will inspire future generations of clinicians and researchers to carry forward the mission of improving lives through science and medicine.

Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Prof. Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Beijing Anzhen Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Yunlong Wang began his illustrious academic journey at the prestigious Peking University Health Science Center, where he earned his Doctor of Cardiology (M.D.). Driven by an unwavering passion for cardiac sciences, he later expanded his expertise internationally through visiting scholar roles at Asklepios St. Georg Hospital, University of Chicago Hospital, and the Hospital of the University of Pennsylvania , specializing in electrophysiology. These experiences provided a robust foundation for his future contributions to cardiac arrhythmia treatment.

Professional Endeavors

Prof. Wang has been a cornerstone of Beijing Anzhen Hospital, Capital Medical University since 2007. As the Chief Physician and Executive Director of the Arrhythmias Ward Three, he oversees the department’s advanced cardiac electrophysiology operations. With unmatched skill, he performs over 1400 tachyarrhythmia radiofrequency ablation procedures annually. In addition to his clinical duties, he is a respected doctoral supervisor, educator for undergraduate medical students, and a key figure in national cardiovascular intervention training programs authorized by China’s National Health Commission.

Contributions and Research Focus

Prof. Wang’s clinical expertise centers on the diagnosis and radiofrequency ablation treatment of complex tachyarrhythmias such as persistent atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. His research portfolio includes pivotal studies in both basic and clinical science. His fundamental research has been supported by the National Natural Science Foundation of China, examining the roles of CRT and the HIF-1α-Nkx2.5 axis in cardiac remodeling and ion channel regulation. His clinical investigations have significantly advanced understanding and treatment of arrhythmias, with more than ten SCI-indexed papers published as lead or corresponding author in the last five years.

Accolades and Recognition

Prof. Wang is a prominent member of several key professional bodies, including the National Committee of the Chinese Society of Biomedical Engineering (Electrocardiogram Technology Branch), and serves on the youth committees of the Heart Rhythm Branch and Beijing Medical Association. His scholarly contributions have been featured in high-impact journals such as Heart Rhythm, Europace, and J Cardiovasc Electrophysiol, affirming his stature in the field of cardiac electrophysiology.

Impact and Influence

Prof. Wang's leadership in arrhythmia treatment has redefined procedural benchmarks across China. By educating the next generation of cardiologists and shaping national training protocols, his influence permeates both clinical and academic spheres. His pioneering research in radiofrequency ablation and cardiac electrophysiology continues to inform best practices globally.

Legacy and Future Contributions

Prof. Wang’s legacy is built on a blend of surgical excellence, scientific inquiry, and educational mentorship. As cardiac electrophysiology continues to evolve, his ongoing research into molecular pathways and ablation techniques is poised to unlock new treatment paradigms. With a steadfast commitment to innovation and clinical precision, he remains a vital contributor to the future of cardiovascular medicine in China and beyond.

 

Publications


The mC2HEST Score for Incident Atrial Fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

  • Authors: Yanguang Li, Qiaoyuan Li, Lili Wang, Tao Zhang, Hai Gao, Daniele Pastori, Zhuo Liang, Gregory Y.H. Lip, Yunlong Wang

  • Journal: JACC: Advances

  • Year: 2025


Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Aging Clinical and Experimental Research

  • Year: 2025


Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: International Journal of Cardiology

  • Year: 2025


Prompt Identification of the Location of Gap Conduction in the Mitral Isthmus Following Vein of Marshall Ethanol Infusion and Endocardial Ablation

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Circulation: Arrhythmia and Electrophysiology

  • Year: 2025


Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy

  • Authors: Ying Xie, Qiaoyuan Li, Xiyun Bian, Yan Yin, Zhuo Liang, Xu Liu, Tao Zhang, Xiaozhi Liu, Xin Quan, Yunlong Wang

  • Journal: Clinical and Translational Medicine (Wiley)

  • Year: 2025


 

Armin Arshi | Medicine and Dentistry | Best Researcher Award

Dr. Armin Arshi | Medicine and Dentistry | Best Researcher Award

NYU Langone Health | United States

Author Profile

Scopus

Google Scholar

🌱 Early Academic Pursuits

Dr. Armin Arshi began his academic journey with distinction, graduating Summa Cum Laude with a Bachelor of Science in Bioengineering from UCLA in 2012. He complemented his technical depth with a specialization in Materials Science and Engineering. Driven by a passion for medicine and innovation, he pursued his Doctor of Medicine at the David Geffen School of Medicine at UCLA, earning membership in the prestigious Alpha Omega Alpha (AΩA) Honor Medical Society and receiving multiple academic awards for excellence in research and leadership.

🏥 Professional Endeavors

Following medical school, Dr. Arshi underwent rigorous Orthopaedic Surgery residency training at UCLA, where he served as Administrative Chief Resident. He then pursued a Fellowship in Adult Reconstruction at the Rothman Orthopaedic Institute, a globally respected hub for joint replacement. His clinical career has included prominent roles as Attending Orthopaedic Surgeon at NYU Langone Health and currently at Beach Orthopaedic Specialty Institute and UCI Health in California. As an Assistant Professor at NYU Grossman School of Medicine, he has shaped orthopedic education and research.

🔬 Contributions and Research Focus

Dr. Arshi’s research spans joint arthroplasty, surgical outcomes, infection control, and implant biomechanics. He has authored numerous peer-reviewed publications in elite journals like The Journal of Arthroplasty and Arthroplasty Today, addressing topics from patient follow-up to periprosthetic joint infection and predictive modeling. His innovative studies have earned recognition at prestigious meetings including AAOS, NASS, and Western Orthopaedic Association. He has also contributed to surgical literature through influential book chapters and national guidelines.

🏅 Accolades and Recognition

Dr. Arshi’s excellence has been honored with the Stafford L. Warren Medal (UCLA’s highest medical school award), numerous resident research awards, and national research prizes, including the NIH DEBUT Competition and Howard Hughes Fellowships. His leadership in orthopedics is further affirmed through roles on editorial boards of major journals and review panels, demonstrating both scientific rigor and peer respect.

🌍 Impact and Influence

With a keen focus on evidence-based medicine, Dr. Arshi’s work has impacted clinical decision-making in joint replacement, particularly in VTE prophylaxis, return-to-sport protocols, and implant longevity. His efforts to understand disparities in patient outcomes and enhance surgical education have made significant strides in advancing personalized orthopedic care. He is a thought leader committed to improving both technical standards and patient experiences.

🔮 Legacy and Future Contributions

Poised at the intersection of clinical mastery and academic excellence, Dr. Arshi is a rising force in orthopaedics. His commitment to innovation, mentorship, and multidisciplinary collaboration positions him to be a lasting influence in orthopedic surgery and medical education. As he continues to lead in surgery, research, and institutional quality initiatives, his legacy will shape the next generation of joint reconstruction techniques and orthopedic leaders.

Publications


📄 Patient characteristics associated with loss to follow-up after total joint arthroplasty
Authors: Ruff G, Sarfraz A, Lawrence KW, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Risk of early manipulation in cemented versus cementless total knee arthroplasty: analysis of the American Joint Replacement Registry
Authors: Schaffler B, Zaniletti I, Arshi A, De M, Schwarzkopf R, Rozell JC
Journal: Journal of Arthroplasty
Year: 2025


📄 Why do total joint arthroplasties get canceled on the day of surgery?
Authors: Sandoval CG, Katzman JL, Connolly P, Grossman EL, Arshi A, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Total joint arthroplasty patients from distressed communities return to sports and physical activities at lower rates
Authors: Cozzarelli NF, Khan IA, Arshi A, Sherman MB, Fillingham YA
Journal: Journal of Arthroplasty
Year: 2025


📄 Aseptic tibial loosening is associated with thickness of the cement: a radiographic case-control study
Authors: Schaffler B, Robin JX, Katzman J, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2024


Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundationreturnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications


📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025


📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025


📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025


📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025


📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016